STOCK TITAN

Ametek, Inc. - AME STOCK NEWS

Welcome to our dedicated page for Ametek news (Ticker: AME), a resource for investors and traders seeking the latest updates and insights on Ametek stock.

AMETEK, Inc. (NYSE: AME) is a leading global provider of industrial technology solutions, with annual sales of over $6 billion. The company operates through two primary segments: the Electronic Instruments Group (EIG) and the Electromechanical Group (EMG). EIG designs and manufactures advanced instruments for the process, aerospace, power, and industrial markets. EMG focuses on highly engineered automation solutions, thermal management systems, specialty metals, and electrical interconnects.

With a workforce of approximately 15,000 employees, AMETEK has a strong presence worldwide, operating over 120 manufacturing locations and maintaining 100 sales and service locations in more than 30 countries. The company is committed to four key growth strategies: Operational Excellence, Strategic Acquisitions & Alliances, Global & Market Expansion, and New Product Development. Through these strategies, AMETEK aims to double its size and profitability within the next five years.

Recent achievements include the acquisition of Paragon Medical for approximately $1.9 billion, further enhancing AMETEK's capabilities in the medical technology sector. The company also declared a regular quarterly dividend of $0.28 per share, reflecting its strong financial performance and commitment to delivering shareholder value.

Founded in 1930 and listed on the NYSE for over 90 years, AMETEK is a component of the S&P 500. The company's disciplined focus on cash generation and capital deployment supports its long-term objective of achieving double-digit percentage growth in earnings per share and superior returns on total capital. For more information, visit www.ametek.com.

Rhea-AI Summary
AMETEK, Inc. announced the appointment of Dalip M. Puri as Executive Vice President and Chief Financial Officer, effective April 2, 2024, replacing William J. Burke. The company's objective is double-digit percentage growth in earnings per share over the business cycle and a superior return on total capital.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.1%
Tags
none
-
Rhea-AI Summary
AMETEK, Inc. announced the retirement of William J. Burke, its Executive Vice President and Chief Financial Officer, after 36 years of service. The company has named Dalip M. Puri to succeed Mr. Burke as Executive Vice President and CFO. AMETEK is a leading global provider of industrial technology solutions with annual sales over $6.0 billion and has been listed on the NYSE for over 90 years.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.1%
Tags
none
-
Rhea-AI Summary
AMETEK, Inc. (NYSE: AME) has completed the acquisition of Paragon Medical, a leading provider of medical components and instruments, in an all-cash transaction valued at approximately $1.9 billion. Paragon's annual sales of approximately $500 million will further broaden AMETEK's presence in the MedTech industry. AMETEK aims for double-digit percentage growth in earnings per share over the business cycle and a superior return on total capital.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.8%
Tags
Rhea-AI Summary
AMETEK (NYSE: AME) released its 2023 Sustainability Report, highlighting a 26% reduction in emissions intensity since 2019, among other environmental achievements.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.12%
Tags
none
-
News
Rhea-AI Summary
AMETEK, Inc. (NYSE: AME) has declared a regular quarterly dividend of $0.25 per share for the fourth quarter ending December 31, 2023. The dividend is payable on December 22, 2023, to shareholders of record as of December 8, 2023. AMETEK is a leading global provider of industrial technology solutions with annual sales over $6.0 billion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
dividends
-
Rhea-AI Summary
American Securities LLC has agreed to sell Paragon Medical to AMETEK, Inc. in an all-cash transaction valued at $1.9 billion. Paragon is a global industry leader in medical components and instruments. The transaction is subject to regulatory approvals.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.46%
Tags
none
Rhea-AI Summary
AMETEK, Inc. has agreed to acquire Paragon Medical, a provider of medical components and instruments, in an all-cash transaction valued at $1.9 billion. Paragon serves specialty applications such as orthopedics, minimally invasive surgery, robotic surgery, and drug delivery. The acquisition expands AMETEK's presence in the MedTech space and provides access to new market segments with strong growth rates. Paragon Medical has annual sales of approximately $500 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.46%
Tags
-
News
Rhea-AI Summary
AMETEK, Inc. has announced the acquisition of Amplifier Research Corp., a leading manufacturer of RF and microwave amplifiers and EMC testing equipment. Amplifier Research has a diverse product portfolio and annual sales of approximately $60 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.46%
Tags
-
Rhea-AI Summary
AMETEK, Inc. (NYSE: AME) reported its financial results for Q3 2023. Sales were $1.62 billion, a 5% increase YoY. Operating income reached a record $438.1 million, up 14%, with operating margins at a record 27.0%. Operating cash flow was a record $473 million, up 45% YoY. GAAP earnings per diluted share were $1.47, while adjusted earnings per diluted share were a record $1.64, up 13% YoY.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.46%
Tags
Rhea-AI Summary
AMETEK, Inc. announces third quarter 2023 earnings call and webcasted investor conference call information
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.23%
Tags

FAQ

What is the current stock price of Ametek (AME)?

The current stock price of Ametek (AME) is $183.36 as of December 20, 2024.

What is the market cap of Ametek (AME)?

The market cap of Ametek (AME) is approximately 42.0B.

What does AMETEK, Inc. do?

AMETEK, Inc. is a global provider of industrial technology solutions, focusing on advanced instruments and engineered automation solutions for various markets.

What are the key business segments of AMETEK?

AMETEK operates through two main segments: the Electronic Instruments Group (EIG) and the Electromechanical Group (EMG).

How many employees does AMETEK have?

AMETEK has approximately 15,000 employees worldwide.

What are AMETEK's growth strategies?

AMETEK's growth strategies include Operational Excellence, Strategic Acquisitions & Alliances, Global & Market Expansion, and New Product Development.

What recent acquisitions has AMETEK made?

Recently, AMETEK acquired Paragon Medical for approximately $1.9 billion, enhancing its capabilities in the medical technology sector.

What is AMETEK's annual sales figure?

AMETEK's annual sales exceed $6 billion.

When was AMETEK founded?

AMETEK was founded in 1930.

Is AMETEK listed on any stock exchange?

Yes, AMETEK is listed on the New York Stock Exchange (NYSE) under the symbol AME.

What is AMETEK's dividend policy?

AMETEK declared a regular quarterly dividend of $0.28 per share, reflecting its strong financial performance.

Where can I find more information about AMETEK?

For more information, visit AMETEK's official website at www.ametek.com.

Ametek, Inc.

NYSE:AME

AME Rankings

AME Stock Data

41.96B
230.21M
0.41%
88.2%
1.15%
Specialty Industrial Machinery
Industrial Instruments for Measurement, Display, and Control
Link
United States of America
BERWYN